Revolve Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
19,211
+5,232
+37% +$458K 0.18% 76
2026
Q1
$1.19M Sell
13,979
-2,043
-13% -$182K 0.15% 78
2025
Q4
$1.27M Sell
16,022
-8,452
-35% -$663K 0.15% 78
2025
Q3
$1.96M Sell
24,474
-157
-0.6% -$13.4K 0.23% 59
2025
Q2
$2.24M Sell
24,631
-337
-1% -$30.8K 0.29% 50
2025
Q1
$2.34M Sell
24,968
-710
-3% -$63.6K 0.34% 43
2024
Q4
$2.33M Sell
25,678
-108
-0.4% -$10.3K 0.34% 46
2024
Q3
$2.68M Buy
25,786
+598
+2% +$61K 0.41% 34
2024
Q2
$2.44M Sell
25,188
-1,972
-7% -$182K 0.4% 38
2024
Q1
$2.45M Sell
27,160
-691
-2% -$58.5K 0.42% 39
2023
Q4
$2.22M Sell
27,851
-1
-0% -$75 0.43% 38
2023
Q3
$1.98M Sell
27,852
-274
-1% -$20.5K 0.46% 41
2023
Q2
$2.17M Sell
28,126
-1,194
-4% -$92.4K 0.51% 38
2023
Q1
$2.2M Sell
29,320
-1,028
-3% -$76.4K 0.56% 37
2022
Q4
$2.39M Buy
30,348
+78
+0.3% +$5.85K 0.68% 32
2022
Q3
$2.13M Buy
+30,270
New +$2.37M 0.71% 29

Other funds holding CL

Revolve Wealth Partners's CL Position: Q2 2026 in Review

Revolve Wealth Partners increased its Colgate-Palmolive (CL) stake by 37% in Q2 2026, buying an estimated $458K and bringing the position to 19,211 shares worth $1.76M. The position accounts for 0.18% of the portfolio, ranked #76.

Revolve Wealth Partners first reported a position in CL in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.68M in Q3 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Revolve Wealth Partners held 19,211 shares of Colgate-Palmolive worth $1.76M as of Q2 2026.
  • Revolve Wealth Partners bought 5,232 Colgate-Palmolive shares in Q2 2026, an estimated $458K.
  • Colgate-Palmolive made up 0.18% of Revolve Wealth Partners's portfolio in Q2 2026, its #76 holding.
  • Revolve Wealth Partners first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 16 quarters since.
  • Revolve Wealth Partners's Colgate-Palmolive position peaked at $2.68M in Q3 2024.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.